ChemicalBook > Product Catalog > Analytical Chemistry > Standard > Pharmaceutical Impurity Reference Standards > Tofacitinib Impurity 6
Tofacitinib Impurity 6
Tofacitinib Impurity 6 Basic information
- Product Name:
- Tofacitinib Impurity 6
- Synonyms:
-
- N-((3R,4R)-1-benzyl-4-methylpiperidin-3-yl)-N-methyl-7H-pyrrolo[2,3-d]pyrimidin-2-amine
- Tofacitinib-21
- Tofacitinib impurity 14/5,6-Dihydro Tofacitinib/3-((3R,4R)-3-((6,7-dihydro-5H-pyrrolo[2,3-d]pyrimidin-4-yl)(methyl)amino)-4-methylpiperidin-1-yl)-3-oxopropanenitrile
- Tofacitinib impurity 15/5,6-Dihydro Tofacitinib Citrate/3-((3R,4R)-3-((6,7-dihydro-5H-pyrrolo[2,3-d]pyrimidin-4-yl)(methyl)amino)-4-methylpiperidin-1-yl)-3-oxopropanenitrile 2-hydroxypropane-1,2,3-tricarboxylate
- Tofacitinib Impurity 39
- 5,6-Dihydro CP-690550
- 3-((3R,4R)-3-((6,7-dihydro-5H-pyrrolo[2,3-d]pyrimidin-4-yl)(methyl)amino)-4-methylpiperidin-1-yl)-3-oxopropanenitrile
- Tofacitinib Related Compound 21
- CAS:
- 1640972-35-5
- MF:
- C16H22N6O
- MW:
- 314.39
- Mol File:
- 1640972-35-5.mol
More
Less
Tofacitinib Impurity 6 Chemical Properties
- Melting point:
- >80°C (dec.)
- Boiling point:
- 583.2±50.0 °C(Predicted)
- Density
- 1.239±0.06 g/cm3(Predicted)
- storage temp.
- -20°C Freezer
- solubility
- DMSO (Slightly), Methanol (Slightly)
- pka
- 6.04±0.60(Predicted)
- form
- Solid
- color
- Pale Yellow to Yellow
More
Less
Tofacitinib Impurity 6Supplier
Nanjing wangzhixing Pharmaceutical Technology Co., Ltd Gold
- Tel
- 15850510341
- shiqingran@wzxchem.com
Hubei Ruinuo Pharmaceutical Technology Co., Ltd Gold
- Tel
- 13165688766
- 3008058303@qq.com
S.Z. PhyStandard Bio-Tech. Co., Ltd.
- Tel
- 0755-4000505016 13380397412
- 3001272453@qq.com
ChemStrong Scientific Co.,Ltd
- Tel
- 0755-0755-66853366 13670046396
- sales@chem-strong.com
Wuxi Zhongkun Biochemical Technology Co., Ltd.
- Tel
- 0510-85629785 18013409632
- sales@reading-chemicals.com
More
Less
Tofacitinib Impurity 6(1640972-35-5)Related Product Information
- Tofacitinib related coMpound 2
- 3-((3S,4S)-4-methyl-3-(methyl(7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino)piperidin-1-yl)-3-oxopropanenitrile
- 3-((3R,4R)-3-((2-chloro-7H-pyrrolo[2,3-d]pyriMidin-4-yl)(Methyl)aMino)-4-Methylpiperidin-1-yl)-3-oxopropanenitrile
- Tofacitinib Impurity 2
- Tofacitinib Impurity 3
- 3-Amino-4-methylpyridine
- N-((3S,4S)-1-benzyl-4-Methylpiperidin-3-yl)-N-Methyl-7H-pyrrolo[2,3-d]pyriMidin-4-aMine
- Methyl (1-benzyl-4-Methylpiperidin-3-yl)carbaMate
- 13-Deoxyepirubicin
- 3-((3R,4S)-4-Methyl-3-(Methyl(7H-pyrrolo[2,3-d]pyriMidin-4-yl)aMino)piperidin-1-yl)-3-oxopropanenitrile
- N-((3R,4R)-1-benzyl-4-methylpiperidin-3-yl)-N-methyl-7H-pyrrolo[2,3-d]pyrimidin-4-amine
- 3-METHOXYCARBONYLAMINO-4-METHYLPYRIDINE
- 1-[2-(2-methoxyphenoxy)ethylamino]-3-(9-methylcarbazol-4-yl)oxypropan-2-ol:hydrochloride
- 7H-Pyrrolo[2,3-d]pyriMidin-4-aMine, N-Methyl-N-[(3R,4R)-4-Methyl-1-(phenylMethyl)-3-piperidinyl]-7-[(4-Met hylphenyl)sulfonyl]-
- Methyl (4-Methylpiperidin-3-yl)carbaMate
- 3-((3S,4R)-4-Methyl-3-(Methyl(7H-pyrrolo[2,3-d]pyriMidin-4-yl)aMino)piperidin-1-yl)-3-oxopropanenitrile
- 4-CHLORO-7-TOSYL-7H-PYRROLO[2,3-D]PYRIMIDINE
- 3-PiperidinaMine, 1-acetyl-N,4-diMethyl-N-1H-pyrrolo[2,3-d]pyriMidin-4-yl-, (3R,4R)- (9CI)